Compare with RPG LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs RPG LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES RPG LIFE SCIENCES ALKEM LABORATORIES/
RPG LIFE SCIENCES
 
P/E (TTM) x 23.3 19.4 120.0% View Chart
P/BV x 5.5 4.6 121.2% View Chart
Dividend Yield % 0.9 1.2 72.9%  

Financials

 ALKEM LABORATORIES   RPG LIFE SCIENCES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-21
RPG LIFE SCIENCES
Mar-21
ALKEM LABORATORIES/
RPG LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs3,150456 690.6%   
Low Rs2,224169 1,314.2%   
Sales per share (Unadj.) Rs741.4235.3 315.1%  
Earnings per share (Unadj.) Rs135.324.2 559.5%  
Cash flow per share (Unadj.) Rs158.334.1 463.6%  
Dividends per share (Unadj.) Rs30.007.20 416.7%  
Avg Dividend yield %1.12.3 48.5%  
Book value per share (Unadj.) Rs616.8130.9 471.4%  
Shares outstanding (eoy) m119.5716.54 722.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.61.3 272.7%   
Avg P/E ratio x19.912.9 153.6%  
P/CF ratio (eoy) x17.09.2 185.4%  
Price / Book Value ratio x4.42.4 182.3%  
Dividend payout %22.229.8 74.5%   
Avg Mkt Cap Rs m321,2445,171 6,212.5%   
No. of employees `000NANA-   
Total wages/salary Rs m16,210947 1,712.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m88,6503,891 2,278.1%  
Other income Rs m2,33211 21,795.3%   
Total revenues Rs m90,9823,902 2,331.6%   
Gross profit Rs m19,424708 2,744.7%  
Depreciation Rs m2,746165 1,667.2%   
Interest Rs m58918 3,291.6%   
Profit before tax Rs m18,421536 3,438.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,243136 1,651.9%   
Profit after tax Rs m16,178400 4,044.4%  
Gross profit margin %21.918.2 120.5%  
Effective tax rate %12.225.3 48.0%   
Net profit margin %18.210.3 177.5%  
BALANCE SHEET DATA
Current assets Rs m69,2881,759 3,940.2%   
Current liabilities Rs m36,041797 4,522.6%   
Net working cap to sales %37.524.7 151.8%  
Current ratio x1.92.2 87.1%  
Inventory Days Days2011 182.8%  
Debtors Days Days66539 12.3%  
Net fixed assets Rs m34,8251,365 2,551.7%   
Share capital Rs m239132 180.7%   
"Free" reserves Rs m73,5172,032 3,617.6%   
Net worth Rs m73,7562,165 3,407.5%   
Long term debt Rs m3437 4,628.4%   
Total assets Rs m104,1143,123 3,333.4%  
Interest coverage x32.330.9 104.3%   
Debt to equity ratio x00 135.8%  
Sales to assets ratio x0.91.2 68.3%   
Return on assets %16.113.4 120.4%  
Return on equity %21.918.5 118.7%  
Return on capital %25.725.5 100.6%  
Exports to sales %22.10-   
Imports to sales %04.9 0.0%   
Exports (fob) Rs m19,555NA-   
Imports (cif) Rs mNA191 0.0%   
Fx inflow Rs m19,5551,283 1,523.9%   
Fx outflow Rs m2,467191 1,292.5%   
Net fx Rs m17,0881,092 1,564.4%   
CASH FLOW
From Operations Rs m12,649583 2,170.8%  
From Investments Rs m-9,985-80 12,544.5%  
From Financial Activity Rs m-2,718-105 2,590.6%  
Net Cashflow Rs m-17398 -4.3%  

Share Holding

Indian Promoters % 57.1 72.1 79.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 19.3 0.2 9,209.5%  
FIIs % 5.4 0.2 2,700.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.9 27.9 153.5%  
Shareholders   86,881 22,768 381.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Indian Indices End Flat Amid High Volatility; Maruti Suzuki & Tech Mahindra Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

RPG LIFE SCIENCES 2020-21 Annual Report Analysis (Annual Result Update)

Nov 3, 2021 | Updated on Nov 3, 2021

Here's an analysis of the annual report of RPG LIFE SCIENCES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of RPG LIFE SCIENCES. Also includes updates on the valuation of RPG LIFE SCIENCES.

ALKEM LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.5% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, ALKEM LABORATORIES has posted a net profit of Rs 5 bn (up 13.5% YoY). Sales on the other hand came in at Rs 27 bn (up 37.1% YoY). Read on for a complete analysis of ALKEM LABORATORIES's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

4 'Digital India' Stocks to Add to Your 2022 Watchlist(Views On News)

Jan 28, 2022

Digitisation is touching every aspect of our lives. As this megatrend picks up pace, there will be companies benefitting from it for years to come.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 28, 2022 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS